TGFB1 and cancer: Further, our pan-cancer analyses revealed three molecular and immunological correlates with ANS expression that were common across cancer types, including angiogenesis, TGF-β signaling, and immunosuppression (measured as TME levels of PD-1, PD-L1, and T-regs).